Real world evidence of adjuvant trastuzumab in HER2 positive early breast cancer

Autor: J. Lluch-Gómez, V. Núñez-Álvarez, C. de la Torre-Hita, M. Bernal-Gómez, A. Campini-Bermejo, E. Perdomo-Zaldívar, L. Rodríguez-Pérez, J. Calvete-Candenas, M. J. Martínez-Bautista, E. Benítez-Rodríguez, J. M. Baena-Cañada

Publikováno v: Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)

Abstract Adjuvant trastuzumab in HER2+ breast cancer reduces recurrence and mortality, and has been the standard treatment since 2006. The objective was to analyze health outcomes in the real world. Observational, retrospective study of patients with

Externí odkaz: https://doaj.org/article/0fb4141de38a494f82b0f7c89a37724a

Abstract P3-09-08: Overeating and breast cancer risk by pathologic subtypes: EpiGEICAM study

Autor: Adela Castelló, A. De Juan, JA Garcia-Saenz, M. Ramos, A. Lluch, Antonio Antón, P. Sanchez Rovira, Beatriz Pérez-Gómez, Jose Ignacio Chacon, Eva Carrasco, Montse Muñoz, Marina Pollán, Virginia Lope, Silvia Antolín, J. M. Baena, Carlos Poblete Jara, A. Ruiz, Susana Bezares, A. Arcusa, M. Martin, M. A. Jimeno, Ana M. Casas

Publikováno v: Cancer Research. 78:P3-09

Introduction: It has been reported that overeating may be the greatest avoidable cause of cancer in nonsmokers and obesity increases postmenopausal breast cancer (BC) risk. Calorie restriction reduces BC incidence in experimental animals, but the evi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4bdc29beb384a1d37d31f638bf93a01b
https://doi.org/10.1158/1538-7445.sabcs17-p3-09-08

Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice

Autor: Elisabeth Pérez-Ruiz, Ana Jaén, M. J. Sotelo, I. Blancas, M. M. Gordon, M. Fontanillas, N. M. Jáñez, Cesar Mendiola, V. Conde, J. S. Bofill, J. Lao, J. M. Baena-Cañada, Andrés García-Palomo, E. Martínez, Josefina Cruz, J. Bayo, F. Carabantes, Jose Juan Illarramendi, Manuel Ruiz-Borrego, G. Esquerdo

Publikováno v: CLINICAL & TRANSLATIONAL ONCOLOGY
r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
instname

This study aimed to describe the efficacy of fulvestrant 500 mg in postmenopausal women with estrogen receptor (ER)-positive advanced/metastatic breast cancer who had disease progression after receiving anti-estrogen therapy in clinical practice, get

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04192f192fdffad21bd803c34d6dbf8d
https://doi.org/10.1007/s12094-017-1797-9

Prediction of cardiovascular disease by the framingham-REGICOR equation in the high-risk PREDIMED cohort: Impact of the mediterranean diet across different risk strata

Autor: Antonio J. Amor, Mercè Serra‐Mir, Miguel A. Martínez‐González, Dolores Corella, Jordi Salas‐Salvadó, Montserrat Fitó, Ramón Estruch, Lluis Serra‐Majem, Fernando Arós, Nancy Babio, Emilio Ros, Emilio Ortega, A. Pérez‐Heras, C. Viñas, R. Casas, L. de Santamaría, S. Romero, E. Sacanella, G. Chiva, P. Valderas, S. Arranz, J. M. Baena, M. García, M. Oller, J. Amat, I. Duaso, Y. García, C. Iglesias, C. Simón, Ll. Quinzavos, Ll. Parra, M. Liroz, J. Benavent, J. Clos, I. Pla, M. Amorós, M. T. Bonet, M. T. Martin, M. S. Sánchez, J. Altirriba, E. Manzano, A. Altés, A. Sala‐Vila, M. Cofán, C. Valls‐Pedret, T. M. Freitas‐Simoes, M. Doménech, R. Gilabert, N. Bargalló, M. Bulló, J. Basora, R. González, A. Díaz‐López, C. Molina, G. Mena, F. Márquez, P. Martínez, N. Ibarrola, M. Sorli, J. García Roselló, F. Martín, N. Tort, A. Isach, A. Salas‐Huetos, N. Becerra‐Tomás, N. Rosique Esteban, J. J. Cabré, G. Mestres, F. Paris, M. Llaurado, R. Pedret, J. Basells, J. Vizcaino, R. Segarra, P. Hernandez‐Alonso, S. Giardina, C. Ferreira‐Pego, C. Papandreou, L. Camacho, E. Toledo, P. Buil‐Cosiales, M. Ruiz‐Canela, J. A. Martínez, B. Sanjulian, A. Sánchez‐Tainta, J. Diez‐Espino, C. Razquin, A. Garcia‐Arellano, E. Goni, Z. Vazquez, N. Berrade, V. Extremera‐Urabayen, S. Eguaras, A. Marti, C. Arroyo‐Azpa, L. García‐Pérez, J. Villanueva Telleria, F. Cortés Ugalde, T. Sagredo Arce, M. D. García de la Noceda Montoy, M. D. Vigata López, M. T. Arceiz Campo, A. Urtasun Samper, M. V. Gueto Rubio, A. Sola, N. Goñi, O. Lecea, S. Tello, J. Vila, R. de la Torre, D. Muñoz‐Aguayo, R. Elosua, J. Marrugat, H. Schröder, N. Molina, E. Maestre, O. Castañer, A. Rovira, M. Farre, J. V. Sorli, V. Zanon‐Moreno, P. Carrasco, C. Ortega‐Azorín, E. M. Asensio, R. Osma, R. Barragán, F. Francés, M. Guillén, J. I. González, C. Saiz, O. Portolés, F. J. Giménez, O. Coltell, P. Guillem‐Saiz, L. Quiles, V. Pascual, C. Riera, M. A. Pages, D. Godoy, A. Carratala‐Calvo, M. J. Martín‐Rillo, E. Llopis‐Osorio, J. Ruiz‐Baixauli, A. Bertolín‐Muñoz, I. Salaverría, T. del Hierro, J. Algorta, S. Francisco, A. Alonso‐Gómez, E. Sanz, J. Rekondo, M. C. Bello, A. Loma‐Osorio, E. Gómez‐Gracia, J. Warnberg, R. Benítez Pont, M. Bianchi Alba, R. Gómez‐Huelgas, J. Martínez‐González, V. Velasco García, J. de Diego Salas, A. Baca Osorio, J. Gil Zarzosa, J. J. Sánchez Luque, E. Vargas López, V. Ruiz‐Gutiérrez, J. Sánchez Perona, E. Montero Romero, M. García‐García, E. Jurado‐Ruiz, M. Fiol, M. García‐Valdueza, M. Moñino, A. Proenza, R. Prieto, G. Frontera, M. Ginard, F. Fiol, A. Jover, D. Romaguera, J. García, J. Lapetra, J. M. Santos‐Lozano, M. Ortega‐Calvo, L. Mellado, M. Leal, E. Martínez, F. José García, P. Román, P. Iglesias, Y. Corchado, L. Miró, C. Domínguez, J. M. Lozano, E. Mayoral, R. M. Lamuela‐Raventós, M. C. López‐Sabater, A. I. Castellote‐Bargallo, A. Tresserra‐Rimbau, J. Álvarez‐Pérez, E. M. Díaz‐Benítez, I. Bautista Castaño, A. Sánchez‐Villegas, M. J. Fernández‐Rodríguez, T. Casanas Quintana, J. Pérez‐Cabrera, M. Nissensohn, V. Díaz‐González, C. Ruano‐Rodríguez, A. P. Ortiz‐Andrelluchi, B. Macías Gutiérrez, A. J. Santana‐Santana, X. Pintó, E. de la Cruz, A. Galera, Y. Soler, F. Trias, I. Sarasa, E. Padres, E. Corbella, C. Cabezas, E. Vinyoles, M. A. Rovira, L. García, G. Flores, J. M. Verdú, P. Baby, A. Ramos, L. Mengual, P. Roura, M. C. Yuste, A. Guarner, M. I. Santamaría, M. Mata, C. de Juan, A. Brau, J. A. Tur, M. P. Portillo, G. Sáez, M. Aldamiz, A. Alonso, J. Berjón, L. Forga, J. Gallego, A. Larrauri, J. Portu, J. Timiraos, M. Serrano‐Martínez

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Digital.CSIC. Repositorio Institucional del CSIC

Background-The usefulness of cardiovascular disease (CVD) predictive equations in different populations is debatable. We assessed the efficacy of the Framingham-REGICOR scale, validated for the Spanish population, to identify future CVD in participan

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f74e88979136faea0721e7c93bd1826
http://hdl.handle.net/10261/166179

P1-14-03: AVALUZ Study: First Line with Bevacizumab in Combination with Paclitaxel (P) and Gemcitabine (G) in Patients with HER-2 Negative Recurrent or Metastatic BC: PFS Analysis

Autor: J. M. Baena, E. González, D Perez, MJ Villanueva, Luis Manso, JR Mel, la Haba J de, Miguel Gil, I. Blancas, de Villena M Codes, Javier Salvador, Eva Ciruelos, J. Bayo, A Galan, Carlos Jara, A Murias, Ana Jaén

Publikováno v: Cancer Research. 71:P1-14

Background The combination of bevacizumab (B) with taxanes, capecitabine or anthracyclines has shown increased PFS in pts with mBC. The combination with G and P has been evaluated and has demonstrated high response rate and good toxicity profile. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ebc0eca1b72ab5937205f21ce09082b1
https://doi.org/10.1158/0008-5472.sabcs11-p1-14-03